By Kim Richters

The U.K. Competition and Markets Authority is reviewing Roche Holding AG's (RO.EB) planned acquisition of Spark Therapeutics Inc. (ONCE), the regulator said Wednesday.

Swiss pharmaceuticals company Roche announced plans to acquire U.S.-based biotechnology company Sparks in February this year.

The authority is considering whether a merger would lead to a substantial lessening of competition within the United Kingdom and it seeks comments on the deal by Oct. 11, it said.

Write to Kim Richters at kim.richters@wsj.com

(END) Dow Jones Newswires

September 25, 2019 02:39 ET (06:39 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Onconetix (NASDAQ:ONCE)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025 Click aqui para mais gráficos Onconetix.
Onconetix (NASDAQ:ONCE)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025 Click aqui para mais gráficos Onconetix.